Search Results - "Moosig, F"

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) by Mohammad, A J, Hot, A, Arndt, F, Moosig, F, Guerry, M-J, Amudala, N, Smith, R, Sivasothy, P, Guillevin, L, Merkel, P A, Jayne, D R W

“…Conventional treatment of eosinophilic granulomatosis with polyangiitis (EGPA) (Churg-Strauss) with glucocorticoids, with or without additional…”
Get more information

Treatment of giant cell arteritis: what is in the pipeline? by Holle, J U, Moosig, F

“…Glucocorticoids (GC) represent the standard treatment in remission induction and maintenance in the treatment of giant cell arteritis (GCA). Additive…”
Get full text

Current treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) by Moosig, F, Holle, J

“…For the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) much less data are available when compared to the other anti-neutrophil cytoplasmic…”
Get full text

Collagenosis and vasculitis-what is allowed in treatment? by Moosig, F, Holle, J

“…There has been a substantial improvement in treatment options for rheumatic diseases due to the approval of many new drugs. This general trend is also…”
Get full text

Genetics of toll like receptor 9 in ANCA associated vasculitides by Husmann, C A, Holle, J U, Moosig, F, Mueller, S, Wilde, B, Cohen Tervaert, J W, Harper, L, Assmann, G, Gross, W L, Epplen, J T, Wieczorek, S

“…To investigate the contribution of genetic polymorphisms of toll like receptor (TLR) 9 and related genes on the susceptibility and clinical manifestation of…”
Get more information

Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica by Baerlecken, N T, Linnemann, A, Gross, W L, Moosig, F, Vazquez-Rodriguez, T R, Gonzalez-Gay, M A, Martin, J, Kötter, I, Henes, J C, Melchers, I, Vaith, P, Schmidt, R E, Witte, T

“…Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are relatively common inflammatory disorders. Establishing the diagnosis however may be difficult,…”
Get more information

Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic by Schulze-Koops, H, Holle, J, Moosig, F, Specker, C, Aries, P, Burmester, G, Fiehn, C, Hoyer, B, Krause, A, Leipe, J, Lorenz, H-M, Schneider, M, Sewerin, P, Voormann, A, Wager, U, Krüger, K, Iking-Konert, C

“…In the current SARS-CoV-2 pandemic there are many questions regarding the safe treatment of patients with inflammatory rheumatic diseases. Many of these…”
Get full text

Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study by Moosig, F, Czech, N, Mehl, C, Henze, E, Zeuner, R A, Kneba, M, Schröder, J O

“…Objective: To quantify 18-fluorodeoxyglucose (FDG) accumulation in large vessels in patients with polymyalgia rheumatica by positron emission tomography (PET),…”
Get full text

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis by Serrano, A, Márquez, A, Mackie, S L, Carmona, F D, Solans, R, Miranda-Filloy, J A, Hernández-Rodríguez, J, Cid, M C, Castañeda, S, Morado, I C, Narváez, J, Blanco, R, Sopeña, B, García-Villanueva, M J, Monfort, J, Ortego-Centeno, N, Unzurrunzaga, A, Marí-Alfonso, B, Sánchez Martín, J, de Miguel, E, Magro, C, Raya, E, Braun, N, Latus, J, Molberg, O, Lie, B A, Moosig, F, Witte, T, Morgan, A W, González-Gay, M A, Martín, J

“…To analyse the role of the PTPN22 and CSK genes, previously associated with autoimmunity, in the predisposition and clinical phenotypes of giant cell arteritis…”
Get more information

Serum HMGB1 levels are increased in active Wegener's granulomatosis and differentiate between active forms of ANCA-associated vasculitis by Wibisono, D, Csernok, E, Lamprecht, P, Holle, J U, Gross, W L, Moosig, F

Get more information

Influence of the IL17A locus in giant cell arteritis susceptibility by Márquez, A, Hernández-Rodríguez, J, Cid, M C, Solans, R, Castañeda, S, Fernández-Contreras, M E, Ramentol, M, Morado, I C, Narváez, J, Gómez-Vaquero, C, Martínez-Taboada, V M, Ortego-Centeno, N, Sopeña, B, Monfort, J, García-Villanueva, M J, Caminal-Montero, L, de Miguel, E, Blanco, R, Palm, O, Molberg, O, Latus, J, Braun, N, Moosig, F, Witte, T, Beretta, L, Santaniello, A, Pazzola, G, Boiardi, L, Salvarani, C, González-Gay, M A, Martín, J

“…Different lines of evidence have highlighted the role of IL-17A in the inflammatory process occurring in giant cell arteritis (GCA). The aim of the present…”
Get more information

Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener's) by Henes, F O, Chen, Y, Bley, T A, Fabel, M, Both, M, Herrmann, K, Csernok, E, Gross, W L, Moosig, F

“…To investigate the correlation of serum levels of high mobility group box 1 (HMGB1) with the extent of granulomatous inflammation in granulomatosis with…”
Get more information

Association of ferritin antibodies with Takayasu arteritis by Große, K., Witte, T., Moosig, F., Hoyer, B. F., Lansche, C., Schmidt, R. E., Baerlecken, N. T.

“…Takayasu arteritis (TA) is difficult to diagnose because diagnostic biomarkers have not yet been established. In a previous study, we detected autoantibodies…”
Get full text

Cortisone-free rheumatology-Distant vision or clinical routine soon? by Holle, J U, Fiehn, C, Moosig, F

Get full text

Clinical spectrum of IgG4-related diseases and the connection to rheumatology by Moosig, F, Schirmer, J H, Lamprecht, P, Holle, J U

“…Rheumatologist should be familiar with the concept of IgG4-related disease (IgG4-RD). Due to the clinical spectrum IgG4-RD can fall directly within the scope…”
Get full text

Polyarteritis nodosa: differential diagnostics and therapy by Schirmer, J H, Holl-Ulrich, K, Moosig, F

“…Polyarteritis nodosa (PAN) is a necrotizing vasculitis of medium size arteries that may affect various organs. The clinical appearance is very variable. The…”
Get full text

Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity by Herrmann, K, Schinke, S, Csernok, E, Moosig, F, Holle, J U

“…Procalcitonin (PCT) is considered to be a specific marker for severe bacterial infections and sepsis. Elevated PCT levels have been reported in active…”
Get full text

P0596 : Association of hepatitis E virus and cryoglobulinemia by Pischke, S, Polywka, S, Schirmer, J.H, Haag, F, Sterneck, M, Luetgehetmann, M, Iking-Konert, C, Dammermann, W, Lueth, S, Moosig, F, Lohse, A.W

Get full text

Development of morbidity and mortality in ANCA-associated vasculitis by Reinhold-Keller, E, Moosig, F

“…The outcome of ANCA (antineutrophil cytoplasmic antibody)-associated vasculitis (AAV) has been significantly improved due to the combined use of…”
Get full text

High white blood cell count in patients with giant cell arteritis predicts an increased risk of stenosis in upper extremity arteries by Both, M, Schulte, K, Moosig, F, Fritzer, E, Gross, Wl, Heller, M, Biederer, J

Get more information